Baxter's AK 98 Hemodialysis Machine Ok'd In US

The FDA has approved Baxter International Inc's (NYSE: BAX) next-generation Artificial Kidney 98 (AK 98) dialysis machine.

• AK 98 Offers a compact, portable, and easy-to-use system for dialysis.
• AK 98 offers encrypted, two-way connectivity, enabling the system to pull prescriptions directly from the electronic medical record for simplified workflow and data handling.
• AK 98 is currently used in more than 90 countries globally and will be available in the U.S. in the coming weeks.
• The dialysis system can be used alongside Theranova, Baxter's novel dialysis membrane.
• Price Action: BAX shares were trading 1.3% higher at $78.74 in premarket trading on the last check Friday.